crypto in the world- Top Related searches

6 Lianban Yibin Paper: The company's current P/B ratio is quite different from that of the same industry. Yibin Paper announced the abnormal fluctuation of stock trading. Since December 6, 2024, the company's stock has been trading daily for six consecutive trading days, with a cumulative increase of 77.12%. According to the data released by CSI official website, the latest P/B ratio of papermaking and packaging owned by the company is 1.69 times, and the latest P/B ratio of the company is 9.28 times. The current P/B ratio of the company is quite different from that of the same industry. Investors are advised to pay attention to risks.Helen Piano's profit distribution plan for the first three quarters: it is planned to distribute 0.32 yuan for 10 shares, and Helen Piano (300329) released the profit distribution plan for the first three quarters of 2024 on the evening of December 13, and it is planned to distribute a cash dividend of 0.32 yuan (including tax) to all shareholders for every 10 shares, with an estimated cash dividend of 8,092,400 yuan.Dongfang Zhizao recorded 7 boards in 9 days, and Dongfang Zhizao recorded 7 daily limit again, with a cumulative increase of 73.59% and a cumulative turnover rate of 262.35%. As of 14:05, the stock traded 353 million shares today, with a turnover of 2.753 billion yuan and a turnover rate of 27.62%. The total market value of the latest A shares reached 10.24 billion yuan, and the circulating market value of A shares was 10.24 billion yuan.

Dongfang Zhizao recorded 7 boards in 9 days, and Dongfang Zhizao recorded 7 daily limit again, with a cumulative increase of 73.59% and a cumulative turnover rate of 262.35%. As of 14:05, the stock traded 353 million shares today, with a turnover of 2.753 billion yuan and a turnover rate of 27.62%. The total market value of the latest A shares reached 10.24 billion yuan, and the circulating market value of A shares was 10.24 billion yuan.China Seismological Network officially measured that a magnitude 3.1 earthquake occurred at 17: 09 on December 13th in Kuqa City, Aksu Prefecture, Xinjiang (41.23 degrees north latitude and 83.31 degrees east longitude) with a focal depth of 21 kilometers.A number of officials from Turkey and Qatar will visit Syria to meet with the Syrian transitional government. On the 12th local time, the Syrian Ministry of Information announced that the Turkish Foreign Minister, the head of the intelligence department and the head of Qatar's national security department will visit Syria and meet with the leader of the Sharm el-Liberation Organization, Giulani, and the caretaker Prime Minister of the Syrian transitional government, Bashir. Up to now, Turkish and Qatar officials have not announced relevant news.

Syrian Human Rights Watch: Israel attacked military facilities in central Syria. On December 13, local time, Syrian Human Rights Watch said that the Israeli army launched an attack on military targets in the Mesyaf area of Hama province in central Syria and the rural area of Homs city in Homs province. (CCTV News)Huatong Co., Ltd.: The sales revenue of live pigs in November was 410 million yuan. Huatong Co., Ltd. announced that in November 2024, the company sold 201,000 pigs, including 10,600 piglets. The sales revenue of live pigs reached 410 million yuan, an increase of 20.56% from the previous month. The average selling price of commercial pigs was 16.5 yuan/kg, down 4.07% from October. In addition, the number of chickens sold in November was 1,205,900, a decrease of 47.69% from the previous month and a year-on-year increase of 19.79%. Chicken sales revenue was 20,213,700 yuan, an increase of 23.65% from the previous month. Sales data are unaudited for investors' reference.Yiling Pharmaceutical Co., Ltd.: The application for clinical trial of Lianhua Yuping Granule was approved, and Yiling Pharmaceutical announced that Beijing Yiling, a wholly-owned subsidiary, received the Notice of Approval for Clinical Trial of Drugs approved and issued by National Medical Products Administration on December 12, 2024, and agreed to carry out clinical trial of Lianhua Yuping Granule for qi deficiency syndrome of common cold.